 | • レポートコード：QYR2104Z3079 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、In Vivo毒性のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験）、用途別市場規模（免疫毒性、全身毒性、発がん性、遺伝毒性、発生毒性・生殖毒性（DART）、その他毒性エンドポイント）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・In Vivo毒性の市場動向 ・企業の競争状況、市場シェア ・In Vivo毒性の種類別市場規模（慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験） ・In Vivo毒性の用途別市場規模（免疫毒性、全身毒性、発がん性、遺伝毒性、発生毒性・生殖毒性（DART）、その他毒性エンドポイント） ・In Vivo毒性の北米市場規模2016-2027（アメリカ、カナダ） ・In Vivo毒性のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・In Vivo毒性のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・In Vivo毒性の中南米市場規模2016-2027（メキシコ、ブラジル） ・In Vivo毒性の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Danaher、Charles River Laboratories、Labcorp、The Jackson Laboratory、Data Sciences International、Envigo、Eurofins Scientific、Perkinelmer、SRI International、Taconic Biosciences、Wuxi Apptec） ・結論 |
In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.
Market Analysis and Insights: Global In Vivo Toxicology Market
The global In Vivo Toxicology market size is projected to reach US$ 6164 million by 2026, from US$ 4194.4 million in 2019, at a CAGR of 5.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In Vivo Toxicology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In Vivo Toxicology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In Vivo Toxicology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In Vivo Toxicology market.
Global In Vivo Toxicology Scope and Market Size
In Vivo Toxicology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In Vivo Toxicology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing
Segment by Application
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity (DART)
Other Toxicity Endpoints
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
Labcorp
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Toxicology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chronic Toxicity Testing
1.2.3 Sub-Chronic Toxicity Testing
1.2.4 Sub-Acute Toxicity Testing
1.2.5 Acute Toxicity Testing
1.3 Market by Application
1.3.1 Global In Vivo Toxicology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunotoxicity
1.3.3 Systemic Toxicity
1.3.4 Carcinogenicity
1.3.5 Genotoxicity
1.3.6 Developmental and Reproductive Toxicity (DART)
1.3.7 Other Toxicity Endpoints
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Toxicology Market Perspective (2016-2027)
2.2 In Vivo Toxicology Growth Trends by Regions
2.2.1 In Vivo Toxicology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In Vivo Toxicology Historic Market Share by Regions (2016-2021)
2.2.3 In Vivo Toxicology Forecasted Market Size by Regions (2022-2027)
2.3 In Vivo Toxicology Industry Dynamic
2.3.1 In Vivo Toxicology Market Trends
2.3.2 In Vivo Toxicology Market Drivers
2.3.3 In Vivo Toxicology Market Challenges
2.3.4 In Vivo Toxicology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Toxicology Players by Revenue
3.1.1 Global Top In Vivo Toxicology Players by Revenue (2016-2021)
3.1.2 Global In Vivo Toxicology Revenue Market Share by Players (2016-2021)
3.2 Global In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In Vivo Toxicology Revenue
3.4 Global In Vivo Toxicology Market Concentration Ratio
3.4.1 Global In Vivo Toxicology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Toxicology Revenue in 2020
3.5 In Vivo Toxicology Key Players Head office and Area Served
3.6 Key Players In Vivo Toxicology Product Solution and Service
3.7 Date of Enter into In Vivo Toxicology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo Toxicology Breakdown Data by Type
4.1 Global In Vivo Toxicology Historic Market Size by Type (2016-2021)
4.2 Global In Vivo Toxicology Forecasted Market Size by Type (2022-2027)
5 In Vivo Toxicology Breakdown Data by Application
5.1 Global In Vivo Toxicology Historic Market Size by Application (2016-2021)
5.2 Global In Vivo Toxicology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In Vivo Toxicology Market Size (2016-2027)
6.2 North America In Vivo Toxicology Market Size by Type
6.2.1 North America In Vivo Toxicology Market Size by Type (2016-2021)
6.2.2 North America In Vivo Toxicology Market Size by Type (2022-2027)
6.2.3 North America In Vivo Toxicology Market Size by Type (2016-2027)
6.3 North America In Vivo Toxicology Market Size by Application
6.3.1 North America In Vivo Toxicology Market Size by Application (2016-2021)
6.3.2 North America In Vivo Toxicology Market Size by Application (2022-2027)
6.3.3 North America In Vivo Toxicology Market Size by Application (2016-2027)
6.4 North America In Vivo Toxicology Market Size by Country
6.4.1 North America In Vivo Toxicology Market Size by Country (2016-2021)
6.4.2 North America In Vivo Toxicology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe In Vivo Toxicology Market Size (2016-2027)
7.2 Europe In Vivo Toxicology Market Size by Type
7.2.1 Europe In Vivo Toxicology Market Size by Type (2016-2021)
7.2.2 Europe In Vivo Toxicology Market Size by Type (2022-2027)
7.2.3 Europe In Vivo Toxicology Market Size by Type (2016-2027)
7.3 Europe In Vivo Toxicology Market Size by Application
7.3.1 Europe In Vivo Toxicology Market Size by Application (2016-2021)
7.3.2 Europe In Vivo Toxicology Market Size by Application (2022-2027)
7.3.3 Europe In Vivo Toxicology Market Size by Application (2016-2027)
7.4 Europe In Vivo Toxicology Market Size by Country
7.4.1 Europe In Vivo Toxicology Market Size by Country (2016-2021)
7.4.2 Europe In Vivo Toxicology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Toxicology Market Size (2016-2027)
8.2 Asia-Pacific In Vivo Toxicology Market Size by Type
8.2.1 Asia-Pacific In Vivo Toxicology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In Vivo Toxicology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In Vivo Toxicology Market Size by Type (2016-2027)
8.3 Asia-Pacific In Vivo Toxicology Market Size by Application
8.3.1 Asia-Pacific In Vivo Toxicology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In Vivo Toxicology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In Vivo Toxicology Market Size by Application (2016-2027)
8.4 Asia-Pacific In Vivo Toxicology Market Size by Region
8.4.1 Asia-Pacific In Vivo Toxicology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In Vivo Toxicology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In Vivo Toxicology Market Size (2016-2027)
9.2 Latin America In Vivo Toxicology Market Size by Type
9.2.1 Latin America In Vivo Toxicology Market Size by Type (2016-2021)
9.2.2 Latin America In Vivo Toxicology Market Size by Type (2022-2027)
9.2.3 Latin America In Vivo Toxicology Market Size by Type (2016-2027)
9.3 Latin America In Vivo Toxicology Market Size by Application
9.3.1 Latin America In Vivo Toxicology Market Size by Application (2016-2021)
9.3.2 Latin America In Vivo Toxicology Market Size by Application (2022-2027)
9.3.3 Latin America In Vivo Toxicology Market Size by Application (2016-2027)
9.4 Latin America In Vivo Toxicology Market Size by Country
9.4.1 Latin America In Vivo Toxicology Market Size by Country (2016-2021)
9.4.2 Latin America In Vivo Toxicology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Toxicology Market Size (2016-2027)
10.2 Middle East & Africa In Vivo Toxicology Market Size by Type
10.2.1 Middle East & Africa In Vivo Toxicology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In Vivo Toxicology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In Vivo Toxicology Market Size by Type (2016-2027)
10.3 Middle East & Africa In Vivo Toxicology Market Size by Application
10.3.1 Middle East & Africa In Vivo Toxicology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In Vivo Toxicology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In Vivo Toxicology Market Size by Application (2016-2027)
10.4 Middle East & Africa In Vivo Toxicology Market Size by Country
10.4.1 Middle East & Africa In Vivo Toxicology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In Vivo Toxicology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In Vivo Toxicology Introduction
11.1.4 Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher In Vivo Toxicology Introduction
11.2.4 Danaher Revenue in In Vivo Toxicology Business (2016-2021)
11.2.5 Danaher Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories In Vivo Toxicology Introduction
11.3.4 Charles River Laboratories Revenue in In Vivo Toxicology Business (2016-2021)
11.3.5 Charles River Laboratories Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Details
11.4.2 Labcorp Business Overview
11.4.3 Labcorp In Vivo Toxicology Introduction
11.4.4 Labcorp Revenue in In Vivo Toxicology Business (2016-2021)
11.4.5 Labcorp Recent Development
11.5 The Jackson Laboratory
11.5.1 The Jackson Laboratory Company Details
11.5.2 The Jackson Laboratory Business Overview
11.5.3 The Jackson Laboratory In Vivo Toxicology Introduction
11.5.4 The Jackson Laboratory Revenue in In Vivo Toxicology Business (2016-2021)
11.5.5 The Jackson Laboratory Recent Development
11.6 Data Sciences International
11.6.1 Data Sciences International Company Details
11.6.2 Data Sciences International Business Overview
11.6.3 Data Sciences International In Vivo Toxicology Introduction
11.6.4 Data Sciences International Revenue in In Vivo Toxicology Business (2016-2021)
11.6.5 Data Sciences International Recent Development
11.7 Envigo
11.7.1 Envigo Company Details
11.7.2 Envigo Business Overview
11.7.3 Envigo In Vivo Toxicology Introduction
11.7.4 Envigo Revenue in In Vivo Toxicology Business (2016-2021)
11.7.5 Envigo Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific In Vivo Toxicology Introduction
11.8.4 Eurofins Scientific Revenue in In Vivo Toxicology Business (2016-2021)
11.8.5 Eurofins Scientific Recent Development
11.9 Perkinelmer
11.9.1 Perkinelmer Company Details
11.9.2 Perkinelmer Business Overview
11.9.3 Perkinelmer In Vivo Toxicology Introduction
11.9.4 Perkinelmer Revenue in In Vivo Toxicology Business (2016-2021)
11.9.5 Perkinelmer Recent Development
11.10 SRI International
11.10.1 SRI International Company Details
11.10.2 SRI International Business Overview
11.10.3 SRI International In Vivo Toxicology Introduction
11.10.4 SRI International Revenue in In Vivo Toxicology Business (2016-2021)
11.10.5 SRI International Recent Development
11.11 Taconic Biosciences
11.11.1 Taconic Biosciences Company Details
11.11.2 Taconic Biosciences Business Overview
11.11.3 Taconic Biosciences In Vivo Toxicology Introduction
11.11.4 Taconic Biosciences Revenue in In Vivo Toxicology Business (2016-2021)
11.11.5 Taconic Biosciences Recent Development
11.12 Wuxi Apptec
11.12.1 Wuxi Apptec Company Details
11.12.2 Wuxi Apptec Business Overview
11.12.3 Wuxi Apptec In Vivo Toxicology Introduction
11.12.4 Wuxi Apptec Revenue in In Vivo Toxicology Business (2016-2021)
11.12.5 Wuxi Apptec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In Vivo Toxicology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chronic Toxicity Testing
Table 3. Key Players of Sub-Chronic Toxicity Testing
Table 4. Key Players of Sub-Acute Toxicity Testing
Table 5. Key Players of Acute Toxicity Testing
Table 6. Global In Vivo Toxicology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global In Vivo Toxicology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global In Vivo Toxicology Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global In Vivo Toxicology Market Share by Regions (2016-2021)
Table 10. Global In Vivo Toxicology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global In Vivo Toxicology Market Share by Regions (2022-2027)
Table 12. In Vivo Toxicology Market Trends
Table 13. In Vivo Toxicology Market Drivers
Table 14. In Vivo Toxicology Market Challenges
Table 15. In Vivo Toxicology Market Restraints
Table 16. Global In Vivo Toxicology Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global In Vivo Toxicology Market Share by Players (2016-2021)
Table 18. Global Top In Vivo Toxicology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vivo Toxicology as of 2020)
Table 19. Ranking of Global Top In Vivo Toxicology Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by In Vivo Toxicology Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In Vivo Toxicology Product Solution and Service
Table 23. Date of Enter into In Vivo Toxicology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In Vivo Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 26. Global In Vivo Toxicology Revenue Market Share by Type (2016-2021)
Table 27. Global In Vivo Toxicology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global In Vivo Toxicology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global In Vivo Toxicology Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global In Vivo Toxicology Revenue Market Share by Application (2016-2021)
Table 31. Global In Vivo Toxicology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global In Vivo Toxicology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America In Vivo Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 34. North America In Vivo Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America In Vivo Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 36. North America In Vivo Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America In Vivo Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America In Vivo Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe In Vivo Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe In Vivo Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe In Vivo Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe In Vivo Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe In Vivo Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe In Vivo Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In Vivo Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific In Vivo Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In Vivo Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific In Vivo Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific In Vivo Toxicology Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific In Vivo Toxicology Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America In Vivo Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America In Vivo Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America In Vivo Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America In Vivo Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America In Vivo Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America In Vivo Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In Vivo Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa In Vivo Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In Vivo Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa In Vivo Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa In Vivo Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa In Vivo Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific In Vivo Toxicology Product
Table 66. Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Danaher Company Details
Table 69. Danaher Business Overview
Table 70. Danaher In Vivo Toxicology Product
Table 71. Danaher Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 72. Danaher Recent Development
Table 73. Charles River Laboratories Company Details
Table 74. Charles River Laboratories Business Overview
Table 75. Charles River Laboratories In Vivo Toxicology Product
Table 76. Charles River Laboratories Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 77. Charles River Laboratories Recent Development
Table 78. Labcorp Company Details
Table 79. Labcorp Business Overview
Table 80. Labcorp In Vivo Toxicology Product
Table 81. Labcorp Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 82. Labcorp Recent Development
Table 83. The Jackson Laboratory Company Details
Table 84. The Jackson Laboratory Business Overview
Table 85. The Jackson Laboratory In Vivo Toxicology Product
Table 86. The Jackson Laboratory Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 87. The Jackson Laboratory Recent Development
Table 88. Data Sciences International Company Details
Table 89. Data Sciences International Business Overview
Table 90. Data Sciences International In Vivo Toxicology Product
Table 91. Data Sciences International Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 92. Data Sciences International Recent Development
Table 93. Envigo Company Details
Table 94. Envigo Business Overview
Table 95. Envigo In Vivo Toxicology Product
Table 96. Envigo Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 97. Envigo Recent Development
Table 98. Eurofins Scientific Company Details
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 101. Eurofins Scientific Recent Development
Table 102. Perkinelmer Company Details
Table 103. Perkinelmer Business Overview
Table 104. Perkinelmer In Vivo Toxicology Product
Table 105. Perkinelmer Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 106. Perkinelmer Recent Development
Table 107. SRI International Company Details
Table 108. SRI International Business Overview
Table 109. SRI International In Vivo Toxicology Product
Table 110. SRI International Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 111. SRI International Recent Development
Table 112. Taconic Biosciences Company Details
Table 113. Taconic Biosciences Business Overview
Table 114. Taconic Biosciences In Vivo Toxicology Product
Table 115. Taconic Biosciences Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 116. Taconic Biosciences Recent Development
Table 117. Wuxi Apptec Company Details
Table 118. Wuxi Apptec Business Overview
Table 119. Wuxi Apptec In Vivo Toxicology Product
Table 120. Wuxi Apptec Revenue in In Vivo Toxicology Business (2016-2021) & (US$ Million)
Table 121. Wuxi Apptec Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vivo Toxicology Market Share by Type: 2020 VS 2027
Figure 2. Chronic Toxicity Testing Features
Figure 3. Sub-Chronic Toxicity Testing Features
Figure 4. Sub-Acute Toxicity Testing Features
Figure 5. Acute Toxicity Testing Features
Figure 6. Global In Vivo Toxicology Market Share by Application: 2020 VS 2027
Figure 7. Immunotoxicity Case Studies
Figure 8. Systemic Toxicity Case Studies
Figure 9. Carcinogenicity Case Studies
Figure 10. Genotoxicity Case Studies
Figure 11. Developmental and Reproductive Toxicity (DART) Case Studies
Figure 12. Other Toxicity Endpoints Case Studies
Figure 13. In Vivo Toxicology Report Years Considered
Figure 14. Global In Vivo Toxicology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global In Vivo Toxicology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global In Vivo Toxicology Market Share by Regions: 2020 VS 2027
Figure 17. Global In Vivo Toxicology Market Share by Regions (2022-2027)
Figure 18. Global In Vivo Toxicology Market Share by Players in 2020
Figure 19. Global Top In Vivo Toxicology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vivo Toxicology as of 2020
Figure 20. The Top 10 and 5 Players Market Share by In Vivo Toxicology Revenue in 2020
Figure 21. Global In Vivo Toxicology Revenue Market Share by Type (2016-2021)
Figure 22. Global In Vivo Toxicology Revenue Market Share by Type (2022-2027)
Figure 23. North America In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America In Vivo Toxicology Market Share by Type (2016-2027)
Figure 25. North America In Vivo Toxicology Market Share by Application (2016-2027)
Figure 26. North America In Vivo Toxicology Market Share by Country (2016-2027)
Figure 27. United States In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe In Vivo Toxicology Market Share by Type (2016-2027)
Figure 31. Europe In Vivo Toxicology Market Share by Application (2016-2027)
Figure 32. Europe In Vivo Toxicology Market Share by Country (2016-2027)
Figure 33. Germany In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific In Vivo Toxicology Market Share by Type (2016-2027)
Figure 41. Asia-Pacific In Vivo Toxicology Market Share by Application (2016-2027)
Figure 42. Asia-Pacific In Vivo Toxicology Market Share by Region (2016-2027)
Figure 43. China In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America In Vivo Toxicology Market Share by Type (2016-2027)
Figure 51. Latin America In Vivo Toxicology Market Share by Application (2016-2027)
Figure 52. Latin America In Vivo Toxicology Market Share by Country (2016-2027)
Figure 53. Mexico In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa In Vivo Toxicology Market Share by Type (2016-2027)
Figure 57. Middle East & Africa In Vivo Toxicology Market Share by Application (2016-2027)
Figure 58. Middle East & Africa In Vivo Toxicology Market Share by Country (2016-2027)
Figure 59. Turkey In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE In Vivo Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 63. Danaher Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 64. Charles River Laboratories Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 65. Labcorp Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 66. The Jackson Laboratory Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 67. Data Sciences International Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 68. Envigo Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 69. Eurofins Scientific Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 70. Perkinelmer Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 71. SRI International Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 72. Taconic Biosciences Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 73. Wuxi Apptec Revenue Growth Rate in In Vivo Toxicology Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のIn-Vitro毒性/毒性試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-Vitro Toxicology/ Toxicity Testing Market The global In-Vitro Toxicology/ Toxicity Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…- 世界のIn-Vitro毒性試験・毒性試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-Vitro Toxicology and Toxicity Testing Market The global In-Vitro Toxicology and Toxicity Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- 世界の放射線毒性（放射線障害、急性放射線症候群）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 20…
- 世界の放射線毒性（放射線障害、急性放射線症候群）市場 2021：企業別、地域別、種類・用途別 The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market player…
- 世界のIn-vitro毒性試験市場規模・現状・予測（2021年-2027年） In-vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. Significant progress in toxicology science is one of the key trends escalating market growth. Besides this, socio-ethical concerns pertaining to animal tests and …